Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cussler

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Developments in Biological Standardization|November 24, 1999
A 4R concept for the safety testing of immunobiologicalsK Cussler
ALTEX|March 15, 2001
[100 years of erysipelas prophylaxis: significance and reduction of animal experiments]K Cussler, E Balks
ALTEX|March 15, 2001
[Clinical endpoints during rabies vaccine control tests]J Hartinger, T Folz, K Cussler
DTW. Deutsche Tierarztliche Wochenschrift|May 10, 2002
[Progress in the replacement of animal experiments in the quality control of clostridial vaccines]K Cussler, E Borrmann, E Werner
Developments in Biologicals|April 8, 2003
Potency testing of inactivated erysipelas vaccines by ELISA--influence of the adjuvant on antibody developmentU Rosskopf-Streicher, S Johannes, K Cussler
FEMS Immunology and Medical Microbiology|July 9, 1999
Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccinesE Ebert, V Oppling, E Werner, et al.
Vaccine|February 13, 2001
Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory testU Rosskopf-Streicher, S Johannes, M Wilhelm, et al.
Pharmeuropa. Special Issue Biologicals|November 14, 2001
Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1K Cussler, U Rosskopf-Streicher, P Volkers, et al.
Veterinary Microbiology|December 20, 2005
Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxinE Borrmann, F Schulze, K Cussler, et al.
Epidemiology and Infection|December 1, 1991
Characterization of a protective protein antigen of Erysipelothrix rhusiopathiaeM H Groschup, K Cussler, R Weiss, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Developments in Biological Standardization|November 24, 1999
A 4R concept for the safety testing of immunobiologicalsK Cussler
ALTEX|March 15, 2001
[100 years of erysipelas prophylaxis: significance and reduction of animal experiments]K Cussler, E Balks
ALTEX|March 15, 2001
[Clinical endpoints during rabies vaccine control tests]J Hartinger, T Folz, K Cussler
DTW. Deutsche Tierarztliche Wochenschrift|May 10, 2002
[Progress in the replacement of animal experiments in the quality control of clostridial vaccines]K Cussler, E Borrmann, E Werner
Developments in Biologicals|April 8, 2003
Potency testing of inactivated erysipelas vaccines by ELISA--influence of the adjuvant on antibody developmentU Rosskopf-Streicher, S Johannes, K Cussler
FEMS Immunology and Medical Microbiology|July 9, 1999
Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccinesE Ebert, V Oppling, E Werner, et al.
Vaccine|February 13, 2001
Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory testU Rosskopf-Streicher, S Johannes, M Wilhelm, et al.
Pharmeuropa. Special Issue Biologicals|November 14, 2001
Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1K Cussler, U Rosskopf-Streicher, P Volkers, et al.
Veterinary Microbiology|December 20, 2005
Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxinE Borrmann, F Schulze, K Cussler, et al.
Epidemiology and Infection|December 1, 1991
Characterization of a protective protein antigen of Erysipelothrix rhusiopathiaeM H Groschup, K Cussler, R Weiss, et al.
Pageof 2